Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02740270 |
| Title | Phase I/Ib Study of GWN323 Alone and in Combination With PDR001 in Patients With Advanced Malignancies and Lymphomas |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ISR | ESP | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Novartis Investigative Site | Chicago | Illinois | 60637 | United States | Details | |
| Novartis Investigative Site | Boston | Massachusetts | 02215 | United States | Details | |
| Novartis Investigative Site | New York | New York | 10017 | United States | Details | |
| Novartis Investigative Site | Houston | Texas | 77030 | United States | Details | |
| Novartis Investigative Site | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| Novartis Investigative Site | Tel Aviv | 6423906 | Israel | Details | ||
| Novartis Investigative Site | Kashiwa | Chiba | 277 8577 | Japan | Details | |
| Novartis Investigative Site | Singapore | 169610 | Singapore | Details | ||
| Novartis Investigative Site | Barcelona | Catalunya | 08035 | Spain | Details |